• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Nycomed sells remaining Diatide shares

Article

Nycomed Amersham this month completed the divestiture of its remaining holdings in Londonderry, NH-based radiopharmaceutical firm Diatide. On June 16, Nycomed finalized the sale of a total of 1.5 million shares of Diatide common stock to a group

Nycomed Amersham this month completed the divestiture of its remaining holdings in Londonderry, NH-based radiopharmaceutical firm Diatide. On June 16, Nycomed finalized the sale of a total of 1.5 million shares of Diatide common stock to a group of private investors. The terms of the sale were not disclosed by either firm.

The two companies will continue their joint marketing efforts for AcuTect, Diatide’s FDA-approved acute deep vein thrombosis agent, and for NeoTect, its agent for lung cancer imaging, which is pending approval. Diatide has begun an aggressive business development program in an effort to find other marketing partners for products in its R&D pipeline, the company said. The sale of Buckinghamshire, U.K.-based Nycomed’s shares brings to a close a partnership begun in 1995, when Nycomed made a $10 million equity investment in Diatide, then known as Diatech (SCAN 8/30/95).

© 1999 Miller Freeman, Inc.All rights reserved.

Related Videos
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.